Cue
Develops and manufactures portable, compact, connected medical diagnostic products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 246 % | 2593 % | (22 %) | (87 %) | (11 %) | 93 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (254 %) | (169 %) | 21 % | (42 %) | (332 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (311 %) | (206 %) | 14 % | (40 %) | (582 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 323 % | 124 % | 7 % | 35 % | 235 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Cue Health is a digital healthcare startup that provides a comprehensive suite of at-home testing services, telehealth consultations, and personalized treatment plans. The company operates in the rapidly growing digital health market, serving a broad range of clients including individuals seeking to manage their health from the comfort of their homes.
Cue Health's business model revolves around its user-friendly mobile application. The app offers a variety of at-home tests for managing heart health, sexual health, food sensitivities, and more. It also provides an FDA-authorized COVID-19 test that delivers lab-quality results in 20 minutes. The company prides itself on the accuracy of its tests, with its COVID-19 test matching lab results with 97.8% accuracy in an independent study by Mayo Clinic.
In addition to testing, the app connects users with healthcare experts for personalized care and treatment plans. This includes a unique GLP-1 treatment plan for weight loss, complete with one-on-one online support. The company also offers a range of prescription treatments that can be ordered directly through the app, providing a seamless, end-to-end healthcare solution.
Cue Health generates revenue through the sale of its at-home tests, telehealth services, and prescription treatments. The company's mission is to empower individuals to live their healthiest lives by making healthcare and health insights more accessible and actionable.
Keywords: Digital Healthcare, At-Home Testing, Telehealth, Personalized Treatment, Mobile App, Heart Health, Sexual Health, Food Sensitivities, COVID-19 Test, Weight Loss.